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Abstract
Autoimmune disorders (AD) are a group of highly disabling pathological conditions that are
growing at an alarming rate affecting approximately 8% of the population. These disorders occur
more frequently in women, as 78% of those diagnosed are women. Little conclusive research has
been conducted as to determine why there is a tremendous sex disparity when looking at the
rates. Due to the overall poor health that results from these disorders, there is an increase in the
societal burden in terms of health care costs, loss of work productivity and reduced quality of
life. The aim of this integrative literature review was to determine the reason for the sex disparity
in autoimmune disorders and to determine the collective disease burden of these disorders on
women. From this review, a determination will be made as to what education and preventative
measure are being directed towards women in an attempt to decrease autoimmune rates. The
literature search for the presented topic was found in the databases of CINAHL, ProQuest
Nursing & Allied Health Sources and PubMed. The terms searched while researching this topic
included: women, autoimmune, prevalence, and sex disparity. Results revealed that the sex
disparity in autoimmunes are due to immunity interaction with female hormones, the presence of
a double X chromosome, and immune response variation between males and females making
their predisposition complex. With alteration of ICD codes to include contributing autoimmune
disorders in death, the true burden of mortality that women face was revealed highlighting the
need for further emphasis and research on this topic. Due to the limited research and knowledge,
nurses need to be advocates for their female patients as they play a vital role in educating women
on their risk and reducing their disease progression.
Keywords: women, autoimmune, prevalence, sex disparities, rise
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Chapter 1: Introduction
Background and Significance
In the past two decades, the rates of autoimmune diseases have expanded exponentially.
Presently, they account for the third most common category of disease in the United States
affecting approximately 5 to 8% of the total population (Fairweather & Rose, 2004). This type of
diverse disease, first described by Ian Mackay and Macfarlane Burnet, is characterized by a
dysfunction in the immune system causing a failure of an organism to tolerate its own cells
resulting in an abnormal immune response by lymphocytes and/or antibodies (Ngo, Steyn &
McCombe, 2014).
Autoimmunity results from an inflammatory state as the body attacks its own cells
causing damage throughout the body's tissues and organs. In these diseases, the body literally
invades itself, causing an inflammatory state while damaging its own tissues and organs at every
site in the body (Fairweather & Rose, 2004). This response can either be classified as organ
specific or systemic depending on the nature of the inflammatory process and cells that the body
deems as “nonself” (Ngo et al, 2014). This state causes its host homeostatic dysfunction resulting
in debilitating symptoms for the individual (Mallampalli, Davies, Wood, Robertson, Polato, &
Carter, 2013). In turn the individual is left with lifelong disabilities and a substantial health and
financial burden due to the chronic nature of these diseases and associated comorbidities
(Mallampalli et al, 2013).
The exact cause of autoimmune disorders has not yet been determined. Current research
widely identifies that autoimmune dysfunction develops as a result of genetically susceptible
individuals becoming exposed to environmental agents which trigger the onset of disease (Ngo et
al, 2014). Each one of the nearly 80 identified autoimmune disorders have been shown to have
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strong association with genetic variability in the human leukocyte antigen gene in combination
with small effects on other genes contributing to the increased genetic susceptibility of certain
individuals (Ngo et al, 2014). This genetic component can attribute to the incidents of
autoimmune related diseases in families as a result of the interaction of common genes,
accounting for an increase in an individual's genetic susceptibility (Ngo et al, 2014). Recent
epidemiological trends in the incident rates also indicate a strong environmental cause, since
large changes in rates over short periods of time cannot be explained by genetics alone
(Mallampalli et al, 2013). The risk of specific autoimmune diseases such as systemic lupus
erythematosus or Graves’ disease, have been linked to such environmental agents such as silica,
pesticides and cigarette smoking (Mallampalli et al, 2013). The link between environmental
exposure and autoimmune dysfunction has been proven in many studies yet, the exact
mechanism of how this correlates is not fully understood (Mallampalli et al, 2013). Thus, it can
be concluded that both genetic and environmental factors play a role in an individual's
susceptibility in the development of one of these diseases.
But how does having two X chromosomes play a role? When examining incidence rates
of autoimmune disease over a population, there is a profound sex disparity. 78% or 6.7 million of
those diagnosed with autoimmune related disorders are women (Fairweather & Rose, 2004).
Collectively, autoimmune diseases account for the fifth leading cause of death to women under
the age of 65 (Mallampalli et al, 2013). Most notable are systemic lupus erythematosus,
rheumatoid arthritis, multiple sclerosis and thyroid related diseases, which are diagnosed in
women at a 9-10 times greater rate than men. As noted before, current research suggests that
autoimmune diseases arise from the interplay between an individual's genetic susceptibility and
environmental agents, yet neither of these causes can explain the role of sex and gender influence
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of the mechanisms leading up to an autoimmune disorder (Mallampalli et al, 2013). While
autoimmune related disorders have been rising in the last decades, the understanding of their
prevalence and incidence is still unknown (Mallampalli et al, 2013).
Problem Statement
Despite researchers knowing of the female prevalence of autoimmune related disorders
for the past 100 years, only recently has attention been paid as to why this occurs (Whitacre,
2001). When first discovered due to their rarity, autoimmune related disorders were looked at
individually, as research tended to focus on questions pertaining to specific disease related
mechanisms (Whitacre, 2001). With recognition that these disorders are collectively linked, the
true extent of the sex disparity in autoimmunes was accepted. Presently, a knowledge gap still
exists as to why there is a sex disparity in autoimmune related disorders. With the rates of
autoimmune disorders rising in women, there is currently no conclusive research to suggest why
this is. These diseases collectively result in a major public health problem due to their chronic
nature which in turn increases societal burden in terms of healthcare costs, work productivity and
reduced quality of life (Mallampalli et al, 2013). Due to this lack of research, the collective
disease burden associated with autoimmunes on women is also unknown (Thomas, Griffiths,
Smeeth, Rooney, & Hall, 2010). The proposed integrative review study has the potential to
determine the nature of the sex disparity in autoimmunes and understand the collective burden of
these disorders.
Purpose of the Integrative Literature Review
The purpose of this intended integrative literature review is first to determine the sex
disparity between men and women in the development of autoimmune related disorders. This
will help advance interventions and knowledge to decrease the likelihood of development of

RATES OF AUTOIMMUNE DISEASE IN WOMEN

8

such disease. The second purpose is to determine the collective burden that these disorders place
on women. Research literature focusing on the specific aspects of the female sex in the role of
autoimmunity will be analyzed and their findings will be reported. From this review, the
interventions to reduce the prevalence of autoimmunes will be addressed as well as any need for
further research and modification of research to reduce the prevalence of these diseases in
women. The literature will allow women to be aware of their overall increased risk of
autoimmune related disorders and specific factors that individually place them at an increased
risk. The literature review also will provide information on the overall increased burden that
autoimmune related disorders have on women.
Research Questions
1. What evidence has been collected to determine the sex disparity in autoimmune related
disorders?
2. What is the burden that women face when diagnosed with an autoimmune related disorder?
3. What is being done to decrease the rates of autoimmune diseases in women?
Conceptual Framework
The lack of research and attention paid to the sex disparity difference between men and
women’s rates of autoimmune disorders may be due to the lack of female specific health
education, prevention and promotion in regards to these disorders. The conceptual framework
used to demonstrate the possible lack of attention to this subject is best described through The
Tannahill Model (Figure 1). The model created by Andrew Tannahill in 1980 consists of three
overlapping spheres of activity health education, prevention and health protection (Tannahill,
2009). Health education is designed to change the knowledge, beliefs, attitudes, and behavior in
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a way that facilitates health (Tannahill, 2009). Prevention aims at ways to decrease risk factors
and minimize the consequences of disease and protection focuses on legal controls and policies
aimed at preventing ill-health and enhancing well-being (Tannahill, 2009). In this review, the
focus is on health education to change the knowledge of women’s risk of autoimmune related
disorders as well as prevention to decrease the sex disparity and minimize the health burden
placed on women when they are diagnosed with autoimmune related disorders. Thus, the model
presented in figure 1 works best for the purposes of the literature review being conducted.

Figure 1: Conceptual Map Rates of Autoimmune Disease in Women
Tannahill, A. (2009). Health Promotion: The Tannahill model revisited. Public Health,
123(5), 396-399.
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Chapter 2: Methods
Research Design
The design of the study presented here is an integrative literature review aimed to
discover the evidence that has been collected to determine the sex disparity in autoimmune
related disorders and to determine the burden that women face when they are diagnosed with an
autoimmune disorder. In order to complete the integrative literature review, the researcher of this
study will conduct a search of literature to find articles on studies that have been conducted that
are appropriate for the criteria listed below. The integrative literature review will be conducted
following the framework of Whittemore and Knalf (2005).
The review will include the stages of an integrative review including problem
identification, literature search, data evaluation, data analysis and presentation. Themes from this
analysis will be evaluated with current literature to support and confirm the current research
regarding women and autoimmune disorders. The information from this review can be used to
provide education to women in regards to their increased risk of autoimmune disorders and bring
to light the collective burden related to a diagnosis.
Literature Search Strategies
For this integrative literature review, the DePaul and Rosalind Franklin University's
search engines were utilized in order to access library databases. To gather sources for this
integrative literature, review the following databases were searched: CINAHL, ProQuest Nursing
& Allied Health Sources and PubMed. The keywords that were used to search the previously
mentioned databases were “women” and “autoimmune” and “prevalence” which yielded eight
sources. Other keywords that were used to search the databases to yield additional articles were
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“sex disparity” and “autoimmune” which yielded another four sources. One article retrieved
from PubMed, which was relevant to this literature review suggested several other studies the
conducted research on the prevalence of autoimmune disorders in women that were useful for
this literature review. When searching the terms, the majority of the research came from journals
regarding women’s health and included a lot of significant information regarding the literature
review.
Literature Search Limitations and Inclusion/ Exclusion Criteria
The search for the integrative literature review was limited to journal articles published
between 1995-2016. Initially, a search was generated using the keywords “women” and
“autoimmune” and “prevalence” returning 9389 results. From this initial search the term “sex
disparity” was added resulting in 564 results of which eight sources were yielded. Another
search was conducted using the key terms “sex disparities” and “autoimmune” which yielded
883 results. When including the keyword “rise” 331 articles resulted in which four articles were
picked. Several articles were also included that were suggested research based on the initial
article included. Studies which did not focus on the link between women and autoimmune
disorders and their collective burden, were excluded, limiting the relevant sources to 15 articles
that discuss the cause of the rising rates of autoimmune disorders in women and their collective
disease burden. See Figure 2 in appendix for diagram of review process.
Data Analysis
The studies that will be included will be organized into a table in which the articles will
be under the following categories that discuss women and autoimmune diseases: author and year;
design, sample and location, aim of study, outcome measures, study results, and study
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the link between autoimmune disorders and sex. Studies presented in the literature review will
explore the sex disparity in autoimmune disorders, current methods of prevention and the
collective burden of these disorders on women.
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Chapter 3: Results
A synthesis across studies in the review of literature in relation to autoimmune disorders
and sex disparities and the collective disease burden on women were analyzed. The chart matrix
will be used in order to evaluate the studies that will be used in the systematic literature review
and to close the knowledge gap which exists as to why there is a sex disparity related to
autoimmune disorders. With the rise of autoimmune disorders, education and collective disease
burden of these disorders need to be determined. As stated in the study by Quintero, et al (2011)
women are at a 2.7 times greater risk of acquiring AD’s than men as they also tend to have a
different age of onset related to reproductive ages coinciding when hormone levels begin to rise
and different disease activity. Another study conducted revealed that with new research showed
that in the UK, autoimmune disorders are a major cause of mortality among females appearing
among the 10 most frequent underlying causes of death while also estimating the contribution of
these disorders to mortality (Thomas et al, 2010). Furthermore, an overall trend in the articles
proved that by grouping autoimmune disorders together helps identify the full extent of the sex
disparity, promote research and identify common determinants for prevention strategies (Thomas
et al, 2010).
Discussion
Hormones
The first theory as to why there is such a higher prevalence of AD’s in women began to
form in 1978 when researchers targeted estrogen in mice as a possible factor that increased a
woman’s susceptibility to these disorders (Squires, 1995). In their study, researchers removed the
gonads in mice and then gave them either testosterone or estrogen exclusively (Squires, 1995).
The results showed that mice who received testosterone were protected from AD’s, whereas the
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mice who received estrogen developed AD’s at a higher rate (Squires, 1995). More recently,
female sex hormones such as estrogen, prolactin, leptin and androgens (testosterone) have all
been examined to determine the exact hormonal role into the development of AD’s due to their
capacity of modulating the immune response via androgen and estrogen receptors (Quintero et al,
2011). In the case of estrogen, the hormone has been shown to direct the immune system to favor
a more T-helper 1 (Th1) lymphocyte domination causing more B cell activation and antibody
production (Quintero et al, 2011). In addition, estrogen acts as an immune- stimulator by
affecting maturation and selection of autoreactive B cells and autoantibody secretion (Quintero et
al, 2011). When administering estradiol into to animal models, the results show an increased the
number of IgE production and induced specific anti-DNA antibody secretion (Moroni, 2012).
Estrogen also affects proinflammatory cytokine synthesis, as it is enhanced in the presence of the
hormone (Whitacre, 2001). This can be seen in the example of systemic lupus erythematosus
(SLE), which has a significant predominance in women (Quintero et al, 2011). In SLE, there is
an imbalance between the hormone relationship resulting in lower immune-suppressive
androgens and higher immune enhancing estrogens (Quintero et al, 2011). When estrogen levels
are high such as in the case of pregnancy, SLE tends to worsen for women displaying the impact
of estrogen on immunity (Quintero et al, 2011).
Other hormones that play a role in predisposing women to AD’s are prolactin and leptin.
Like estrogen, prolactin acts as an immune stimulator affecting B cells and autoantibody
secretion (Quintero et al, 2011). Prolactin reconstitutes humoral and cell mediated immune
responses and are greater in females as a result of the effects of oestrogens (Da Silva, 1995).
Prolactin has been shown to enhance autoimmunes worsening disease severity (Ngo et al, 2014).
Leptin, in conjunction with estrogen has shown to also play a role in the development of
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autoimmunity as it is a potent modulator of the immune response (Merrill, 2015). Specifically,
leptin has been linked to the initiation of autoimmune thyroid disease as it has a direct effect on
the thyroid through inflammatory molecules (Merrill, 2012). With an increased level of leptin,
there is enhanced inflammation creating the foundation for thyroid autoimmunity (Merrill,
2012). These two hormones like estrogen that are increased in women, play a role in the
enhancement of the overall immune response giving more opportunity for the development of an
autoimmune response.
The last hormone affects the chances of autoimmune development are androgens.
Androgens in contrast with the other hormones mentioned above are commonly associated with
the development of masculine characteristics, as they are high in males and remain at a low level
throughout a female's lifetime (Ngo et al, 2014). Like estrogen, androgens affect the immune
system, such as testosterone which reduces the proliferation and differentiation of lymphocytes
as well as inhibits the cytotoxic activity of NK cells (Ngo et al, 2014). These findings coupled
with the reduced rates of autoimmunity in males show that androgens may play a protective role
in autoimmunity (Da Silva, 1995). Despite the many hormonal influences that impact the
immune system, the main female, estrogen and male, testosterone hormones have a large role in
determining one’s predisposition to the development of an autoimmune.
The X Factor
The second mechanism proposed as to why AD’s are more prevalent in females traces
back to the very reason that a human is female or male, the presence of XX or XY. Contrasting
the Y chromosome, which has many fewer genes, the X chromosome contains over 1000 genes
that are essential to cell development and viability (Quintero et al, 2012). During early female
development, one of the x chromosomes and its genes, is inactivated to balance the amount of X
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chromosomal genes in females (Dai & Ahmed, 2014). Despite this precision, this process is not
always 100% accurate as 15% of the X chromosome linked genes escape, allowing expression
on both copies of the X chromosomes to be present (Dai & Ahmed, 2014). Since many of the
immune related genes are located on the X chromosome, the differential expression,
overexpression, and/ or mutation of these one or both of these genes contribute to the sex
differences in immune response (Dai & Ahmed, 2014). For example, the gene Foxp3 is located
on the arm of the X chromosome and is essential for T cell regulation (Moroni et al, 2012). A
deficiency or mutation in this gene can lead to early onset, highly aggressive, and often fatal
multiorgan AD’s (Moroni et al, 2012). Environmental agents that cause demyelination of the X
chromosome can also contribute to a defective gene mutation causing T cell overexpression,
autoreactivity and cytotoxic proinflammatory properties again leading to the development of
AD’s (Mallampalli et al, 2013). An additional mechanism of skewed X chromosome inactivation
during early development could also possibly lead to inactivation of genes that protect against
autoimmunity or the overexpression of a susceptibility gene leading to an increase in AD
predisposition (Quintero et al, 2012). These combined elements influencing the X chromosome
and its gene expression result in the increased likelihood and predisposition that women have
towards developing an autoimmune.
Immune Differences
The final key aspect in determining why there is such an increased rate of autoimmunes
in women, emanates from the difference in immune response in the sexes. Overall, women
respond to infection, vaccination, and trauma with increased antibody production, whereas in
men, inflammation becomes more severe resulting in an increased mortality (Fairweather et al,
2008). Despite this increased antibody production, which protects women against infection, it is
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a double-edged sword when it comes to the development of autoimmunity (Fairweather et al,
2008). With an increased antibody response, there is an increased risk of developing an
autoimmune disorder as the number of autoantibodies present in an individual is a good predictor
and escalates the risk of developing an AD (Fairweather et al, 2008). Additionally, with more
antibody activation, T cell activation is more vigorous and women have a higher absolute
number of CD4 lymphocytes (Fairweather et al, 2008). The number of antibodies, extreme T cell
activation and higher number of CD4’s all are contributing factors to the increased immune
response seen during an autoimmune disorder (Whitacre, 2001). This increased immune
reactivity and greater immunocompetence found in women make them more prone to developing
autoimmune disorders, which could account for the overall higher rates of the disorder (Ngo et
al, 2014).
Finally, the role of miRNA also contributes to the difference in sex immunity. miRNA
are a group of endogenously expressed, small, non-protein coding RNAs that regulate gene
expression post transcriptionally and have different patterns of expression between males and
females in the context of autoimmunes (Dai & Ahmed, 2014). This difference in expression of
immune cells which regulate immune- linked genes, leads to the difference in disease
susceptibility and severity between males and females (Dai & Ahmed, 2014). Environmental
stimuli and pathological changes alter the expression of these miRNAs, for example, ionizing
radiation, which can alter the downregulation of some miRNAs in women, but have no effect in
males (Dai & Ahmed, 2014). The regulation of specific miRNAs on immune function is not fully
understood despite several studies showing the differences of their expression between the sexes,
thus more research needs to conducted to fully understand the role they play in autoimmunity
(Dai & Ahmed, 2014). The combination of all these factors, antibodies, T cells, CD4 and
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miRNA in women, cause a greater risk of developing autoimmunes based on the delicate balance
and higher reactivity that the immune system must maintain.
Collective Burden on Women
Now that contributing factors behind the increased susceptibility of women to ADs have
been determined, the collective burden that these increased rates have on them can be
established. As mentioned before, the consequence of diagnosis of an autoimmune result in
chronic ill health, poor quality of life and major health care costs (Thomas et al, 2010). These
factors place an enormous burden on their hosts, which are predominantly women. In attempt to
determine this collective burden, two separate studies examined death certificates, one from the
US and one from the United Kingdom, to determine if alteration of ICD codes for underlying
contributing autoimmune disorders would affect the ranking of the top official leading causes of
death (Walsh & Rau, 1995). Current ICD classifications are limited and do not account for
autoimmunes because disorders are listed under separate organ systems (Thomas et al, 2003). In
1995, US results showed that within two groupings of ADs, autoimmune related deaths exceeded
the count for the 10th leading cause of death in all age groups younger than 65 (Walsh & Rau,
1995). Similar results were found in the UK from 2003, where autoimmunes were ranked as the
7th leading cause of death for women between the ages of 1-54 (Thomas et al, 2010). The
limitation in classification of ICD codes have essentially hidden the combined burden of
mortality for women due to autoimmunes due to their limited classification (Thomas et al, 2003).
This is important because ICD rankings are the source of important information for health
policymakers and those responsible for delivering health care, as well as highlight areas for
further research on treatment and prevention on conditions (Thomas et al, 2003). Without
recognition that ADs are a major leading cause of death for women, further research and
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exploration in treatment and prevention will not be conducted and the burden of ADs on women
as well as the healthcare system will rise (Thomas et al, 2003). Autoimmunes remain neglected
in the ICD ranking lists and collective impact of autoimmune disorders on female health will
continue to be masked (Thomas et al, 2003).
Conclusion
Based on the proposed literature review, it is apparent that the etiology behind the
increased rates of autoimmunes in women is complex. There is not a definitive cause or
contributing factor that predisposes women to this increased risk of their development, rather the
inner workings of hormones, the double X chromosome, and the variation between immune
response seen in women combined creates the ideal conditions for autoimmunity to develop.
Based on multiple studies, researchers have determined that the interaction between hormones
and the immune system is the most convincing theory to date to explain the sex difference in
AD’s having a strong influence on predisposition based on the rates (Quintero et al, 2012).
Although not discussed, genetics factors outside of the X chromosome and the environment can
also trigger the onset of an autoimmune and further research is needed in order to determine their
interaction with the elements discussed above (Quintero et al, 2012). Major understanding of the
hormonal, genetic and epigenetic process related to sex differences in AD’s may gain further
insight into answering the questions proposed as AD’s continue to be a leading cause of death
among young and middle aged women (Quintero et al, 2012). By grouping AD’s together, rather
than looking at each individually, emphasis will be placed on their shared pathogenesis bringing
to light the true burden of these disorders on women and promote research needed to identify
common determinants (Thomas et al, 2010). Finally, research is needed to explore the opposite
conclusions, why are autoimmunes less prevalent in males and could there be a factor that is
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protective to explain this phenomenon (Quintero et al, 2012).
Future Directions and Nursing Limitations
The current body of research regarding sex and autoimmunity is very limited and vague.
More research is needed to understand the extent of the sex differences in AD’s and their
etiology to begin to develop new treatments to suppress the progression of these disorders
(Whitacre, 2001). New findings from researchers at Ohio State have suggested and began to test
a new type of treatment known as oral tolerance therapy, which targets the destructive cell lines
that turn off the destructive part of the immune system and reduce attacks on the brain tissue in
MS patients (Squires, 2016). More emphasis on this type of research in sex differences and
autoimmune treatments needed to be encouraged in order to gain advancements in this field to
identify further prevention strategies (Thomas et al, 2010).
Regardless of the etiology of the development of an autoimmune, results from alteration
of ICD codes show that AD’s constitute a major public health issue for women (Thomas et al,
2010). Nurses play a vital role in identifying and educating women who have an increased risk of
the development of autoimmunes in order to reduce their chances of progression. Due to the
limited research and knowledge that is available on these disorders, nurses need to be advocates
for their female patients, encouraging them to seek the highest level and most appropriate care
for treatment. This includes advocating for expert opinions on rare disorders in account of the
burden of mortality that women face once diagnosed (Thomas et al, 2010). In addition to
educating their patients, nursing as a profession needs to be educated regarding the disparity of
autoimmunes between the sexes so that they can properly treat patients as well as help advocate
for more research in this field. Since the 1970s when the difference in autoimmunity between the
sexes was first identified, major progression in research has been made in identifying factors that
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contribute to this discrepancy (Squires, 2016). More extensive studies are needed to identify
treatment options that will reduce the effect of the identified factors which predispose women to
developing autoimmunity.
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Appendix
Figure 2: Diagram of Review Process
A diagram was created to display the process used to review the articles selected and
studies that were included. This method enables readers to reproduce the search results and gain
knowledge into the methods used to obtain information about this research topic. An initial
diagram is depicted below in Figure 2.

Number of Studies Found
Using Keywords

Number of Studies
Meeting Inclusion
Criteria

CINAHL

PUBMED

N= 135

N=4364

PROQUEST NURSING &
ALLIED SOURCE
N=49

120

12

351

23

10

128

10

6

20

Number of Studies After
Excluding
Duplicates

Number of Studies After
Using Exclusion
Criteria and
Background
Articles

15

Number of Studies Selected Based on Total Content:
Figure 2: Diagram of Review Process and Study Selection.
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Table of Literature
AUTHOR/ DESIGN,
YEAR
SAMPLE,
LOCATION

AIM OF
STUDY

OUTCOME
MEASURES

STUDY
RESULTS

STUDY
CONCLUSIONS

D.
Fairweathe
r and N.
Rose
(2004)

Literature
Review

To determine
the link
between high
incidences of
autoimmunes
in women and
families with
possible
precursor
inducing
infectious
agents.

Studying the
early differences
in cytokine
response to CB3
infection in
susceptible or
resistant mice to
determine if this
could provide
clues to the
progression to
autoimmunity.

Sex hormones
increase
myocarditis in
female and
male mice by
increasing
interleukin and
tumor necrosis
factor levels in
the heart. The
myocarditis
virus can
trigger
autoimmune
disease in
susceptible
mice by
immunemediated
mechanisms.

The precise
interaction between
hormones and the
innate immune
response after
infection is poorly
understood. Vitro
studies of immune
cells cultured in the
presence of
hormones have
shown that estrogen
significantly
increases
proinflammatory
cytokine production.
The elevated
immune response in
women may further
amplify the adjuvant
effect if infection
thereby increasing
the chronic
autoimmune
likelihood in
women.

C.
Whitacre
(2001)

Commentary

To understand
the biology of
the sex
difference in
autoimmune
disorders as
well as
opportunities
for focused
research on
priorities in
sex
differences.

To examine the
history behind
the increasing
focus in the sex
differences in
autoimmune
rates and to
determine where
research should
follow.

More research
is required in
the basic
immune
response and
the sex
differences that
play a role in
autoimmunity.

Differences between
the stimulation of
male and female
innate immune
response by
pathogens must be
studies as well as
more clarification as
to the male versus
female differences
in the adaptive
immune response.

Johns
Hopkins
University
Baltimore,
Maryland

The Ohio
State
University,
Columbus
Ohio
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Thomas,
S.,
Griffiths,
C. et al
(2010)

Analysis of
1993-2003
death
certificates
that listed
autoimmune
conditions as
underlying or
contributory
causes of
death.
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There is a lack
of population
based studies
based on
autoimmune
disorders and
little is known
about the
collective
disease burden
associated.

To determine the
collective
disease burden
of mortality
from
autoimmune
diseases among
females in the
UK.

In 2003,
autoimmunes
were the 6-7th
leading most
frequent
underlying
cause of death
among females
in all age
groups 75 or
below. The
proportions of
females dying
with an
autoimmune
remained
constant and
deaths were
underestimated
during this
time.

Autoimmune
diseases are a
leading cause of
death among
females in England
and Wales, but their
collective impact
remains hidden in
current disease
classification
systems. Grouping
these together may
help promote
research needed to
identify common
determinants and
future prevention
strategies.

Peer
Reviewed

S. Walsh
and L. Rau
(2000)

Counts of 24
autoimmune
disorders
were
compared
with the
frequencies of
10 “official”
leading
causes of
death in
women in the
US in 1995.

To determine
if autoimmune
diseases cause
sufficient
mortality
among women
to constitute a
leading cause
of death.

Measured the
number of
autoimmune
disorders that
fell into each age
category and
compare these
counts to the 10
leading causes of
death.

Autoimmune
deaths
exceeded the
frequency of
the 10th
leading cause
of death in
every age
category for
women less
than 65 and
exceeded the
that for the 8th
leading cause
in 15-24 and
25-44.

Autoimmune
diseases constitute a
leading cause of
death among young
and middle aged
women.

M.
Mallampall
i et al.
(2013).

Report

To address the
issues of the
limited
research on
autoimmune
environmental
research and
limited
research
regarding the
role of sex in

The roundtable
discussion
resulted in the
conclusions as to
why there is this
gap in the
research and
how the
community can
fix this
knowledge gap.

Sex
differences,
epigenetics,
and the
environment
all interact
with each other
in playing a
role in
developing an
AD although

While progress had
been made, it has
been slow and
preliminary limited
to a few
autoimmune
disorders. Further
identification of
environmental
agents and studies
on their interaction

George
Washington
University,
District of
Columbia
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the
environmentall
y influenced
mechanisms
leading to an
autoimmune
development to
propose future
research
recommendati
ons.
S.T. Ngo,
F.J. Steyn,
and P.A.
McCombe
(2014)

Literature
Review

L. Moroni,
I. Bianchi,
and A.
Lleo
(2012)

Literature
Review,
Survey of
Geological
Area

University of
Queensland
Centre for
Clinical
Research,
Herston
Queensland
Australia

IRCCS
Instituto
Clinico
Humanitas,
Razzano,
Italy
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these
mechanisms
are still not
well known.

with genetic
components in the
development of
ADs may prevent
the rise in rates.

Summarize
human data to
provide an
overview of
the prevalence
in males and
females in
common
autoimmune
diseases in
countries
commonly
surveyed. Then
discuss the
possible
mechanisms
for sex specific
differences.

Examination of
possible
mechanisms for
sex specific
differences
including gender
differences in
immune
response, organ
vulnerability,
reproductive
capacity with
pregnancy, sex
hormones,
genetic
predisposition,
parental
inheritance and
epigenetics.

Evidence
demonstrates
that gender and
sex have a
significant
influence on
the
development
of an
autoimmune
disease. .

Considerations of
gender should be at
the forefront of all
studies that attempt
to define
mechanisms the
underpin
autoimmune
disorders.

Describe geo
epidemiologica
l aspects
related to the
study of
autoimmune
conditions and
its female
prevalence. To
attempt to
focus on the
critical issues
of the lack of
knowledge of
the mechanism
of influence.

Studying the
distribution of
autoimmunes
across various
global regions
and ethnic
groups by means
of
geoepidemiolog
y to provide data
and advance the
understanding of
their
pathogenesis.

Females
overall have
higher rates of
autoimmunes
due to
environmental
factors, sex
hormones and
the presence of
the extra X
chromosome.

The study of sex
differences in
autoimmunity will
help towards better
definition of the
mechanisms leading
to the widely
different
autoimmune clinical
features, allowing a
clear definition of
the cases more
likely to progress or
to present major
complications and
to develop novel
therapeutic
approaches.
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S. Squires
(1995)

Review
The
Washington
Post

D.
Fairweathe
r, S.
FrisaanchoKiss, and
N. Rose
(2008)

Review

O.
Quintero,
M.
AmadorPatarroyo,
G.
MontoyaOrtiz, and
A. RojasVillarraga

Literature
Review

Johns
Hopkins
Medical
Institutions,
Baltimore
Maryland

Universidad
del Rosario,
Bogotá,
Colombia

29

Doctors have
long known
that women
suffer
disproportionat
ely from
autoimmune
disorder but
why is this?

Examine the
latest research to
determine if
factors other
than estrogen
could be the
cause of these
higher rates of
autoimmunes in
women.

Pregnancy may
protect women
against getting
autoimmune
disorders as
pregnancy can
be somewhat
protective
where the body
is more lenient
on detecting
foreign
invaders.

A possible new type
of treatment known
as oral tolerance
therapy has been
tested in mice and
has shown that it
can turn off the
destructive part of
the immune system
and reduce the
attacks. This could
be a promising new
drug that could be
used in humans.

Discusses the
distribution of
autoimmune
disease based
on sex and age
showing the
autoimmune
disease
progress from
an acute
pathology
associated with
an
inflammatory
immune
response to a
chronic
pathology.

Examine the
distinction
between acute
and chronic
pathology as it
impacts the
understanding of
sex differences
in autoimmune
diseases.

There is a
difference
between Th1
and Th2
mediated
pathology
when looking
at the
distribution
between males
and females.
Females have
an increased
incidence
appearing
chronically
later in life
when chronic
pathology,
fibrosis and
increased
numbers of
autoantibodies
are present.

Due to the fact that
there is a difference
between acute and
chronic phases of
disease are
regulated differently
in males females,
distinguishing these
two pathological
phases in animal
models and patients
could lead to more
effective treatments.

To determine
the exact
causes in the
differences in
autoimmune
trends seen
between men
and women.

Examine the
exact differences
in hormonal
influence on the
immune system
as well as how
specific female
hormones
influence
autoimmune

Autoimmunes
are complex
and
multifactorial
entities which
genetic,
epigenetics and
hormonal
differences
strongly

The more frequent
the autoimmune is
and later it shows up
the more women are
affected. Additional
efforts need to
explore why AD’s
are prevalent in
males and if there is
a group of
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severity.
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influence the
predisposition
of women.

protective factors
that could explain
this.

